Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network meta-analysis.
Pietro AmeriVincenzo De MarzoGiuseppe Biondi ZoccaiLucia TricaricoMichele CorrealeNatale Daniele BrunettiMarco CanepaGaetano Maria De FerrariDavide CastagnoItalo PortoPublished in: European heart journal. Cardiovascular pharmacotherapy (2022)
Expanding pharmacotherapy beyond NEUi improves outcomes in HFrEF with CKD.